Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice

Kidney International

Volumn 82, Issue 3, 2012, Pages 292-303

  Nadarajah, Renisha ^a   Milagres, Rosangela ^a   Dilauro, Marc ^a   Gutsol, Alex ^a   Xiao, Fengxia ^a   Zimpelmann, Joseph ^a   Kennedy, Chris ^a   Wysocki, Jan ^b   Batlle, Daniel ^b   Burns, Kevin D ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ACE2; albuminuria; angiotensin; apoptosis; diabetes; podocyte

Indexed keywords

ALBUMIN; ANGIOTENSIN CONVERTING ENZYME 2; MESSENGER RNA; NEPHRIN; PROTEIN; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1;

ACE2 GENE; ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; ENZYME ACTIVITY; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GLOMERULUS; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

EID: 84863802059     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2012.83     Document Type: Article

References (39)

1. Donoghue M, Hsieh F, Baronas E et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res 2000; 87: e1-e9.
2. Tipnis S, Hooper N, Hyde R et al. A human homolog of angiotensin- converting enzyme. J Biol Chem 2000; 275: 33238-33243.
3. Freeman EJ, Chisolm GM, Ferrario CM et al. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996; 28: 104-108. (Pubitemid 26231097)
4. Sampaio WO, Henrique de Castro C, Santos RA et al. Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 2007; 50: 1093-1098. (Pubitemid 350172931)
5. Su Z, Zimpelmann J, Burns KD. Angiotensin-(1-7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int 2006; 69: 2212-2218. (Pubitemid 43882108)
6. Rice G, Thomas D, Grant P et al. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 2004; 383: 45-51. (Pubitemid 39389449)
7. Ye M, Wysocki J, Naaz P et al. Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoprotective combination? Hypertension 2004; 43: 1120-1125. (Pubitemid 38579924)
8. Soler M, Wysocki J, Ye M et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int 2007; 72: 614-623. (Pubitemid 47312795)
9. Wong D, Oudit G, Reich H et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am J Pathol 2007; 171: 438-451. (Pubitemid 47344677)
10. Oudit G, Liu G, Zhong J et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 2010; 59: 529-538.
11. Liu CX, Hu Q, Wang Y et al. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol Med 2011; 17: 59-69.
12. Batlle D, Wysocki J, Soler MJ et al. Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy. Kidney Int 2011; 81: 520-528.
13. Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83: 253-307. (Pubitemid 36459882)
14. Toyoda M, Najafian B, Kim Y et al. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy. Diabetes 2007; 56: 2155-2160. (Pubitemid 47195834)
15. Ye M, Wysocki J, Soler M et al. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J Am Soc Nephrol 2006; 17: 3067-3075. (Pubitemid 44707767)
16. Durvasula RV, Shankland SJ. Activation of a local renin angiotensin system in podocytes by glucose. Am J Physiol Renal Physiol 2008; 294: F830-F839.
17. Velez JC, Bland AM, Arthur JM et al. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes. Am J Physiol Renal Physiol 2007; 293: F398-F407. (Pubitemid 47345041)
18. Yoo TH, Li JJ, Kim JJ et al. Activation of the renin-angiotensin system within podocytes in diabetes. Kidney Int 2007; 71: 1019-1027.
19. Inoki K, Mori H, Wang J et al. mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice. J Clin Invest 2011; 121: 2191-2196.
20. Hsu HH, Hoffmann S, Di Marco GS et al. Downregulation of the antioxidant protein peroxiredoxin 2 contributes to angiotensin II-mediated podocyte apoptosis. Kidney Int 2011; 80: 959-969.
21. Jia J, Ding G, Zhu J et al. Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis. Am J Nephrol 2008; 28: 500-507. (Pubitemid 351501616)
22. Reich HN, Oudit GY, Penninger JM et al. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int 2008; 74: 1610-1616.
23. Benter IF, Yousif MH, Cojocel C et al. Angiotensin-(1-7) prevents diabetes-induced cardiovascular dysfunction. Am J Physiol Heart Circ Physiol 2007; 292: H666-H672. (Pubitemid 46105230)
24. Putaala H, Soininen R, Kilpeläinen P et al. The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001; 10: 1-8. (Pubitemid 32051561)
25. Benigni A, Gagliardini E, Tomasoni S et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy. Kidney Int 2004; 65: 2193-2200. (Pubitemid 38670005)
26. Doublier S, Salvidio G, Lupia E et al. Nephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II. Diabetes 2003; 52: 1023-1030. (Pubitemid 36384273)
27. Hussain S, Romio L, Saleem M et al. Nephrin deficiency activates NF-kappaB and promotes glomerular injury. J Am Soc Nephrol 2009; 20: 1733-1740.
28. Qi Z, Fujita H, Jin J et al. Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes 2005; 54: 2628-2637. (Pubitemid 41233584)
29. Gil N, Goldberg R, Neuman T et al. Heparanase is essential for the development of diabetic nephropathy in mice. Diabetes 2012; 61: 208-216.
30. Zheng S, Huang Y, Yang L et al. Uninephrectomy of diabetic OVE26 mice greatly accelerates albuminuria, fibrosis, inflammatory cell infiltration and changes in gene expression. Nephron Exp Nephrol 2011; 119: e21-e32.
31. Habibi J, Hayden MR, Sowers JR et al. Nebivolol attenuates redoxsensitive glomerular and tubular mediated proteinuria in obese rats. Endocrinology 2011; 152: 659-668.
32. Menini S, Iacobini C, Oddi G et al. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease. Diabetologia 2007; 50: 2591-2599. (Pubitemid 350060642)
33. Ziyadeh FN, Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 2008; 4: 39-45. (Pubitemid 351210971)
34. Zimpelmann J, Burns KD. Angiotensin-(1-7) activates growth-stimulatory pathways in human mesangial cells. Am J Physiol Renal Physiol 2009; 296: F337-F346.
35. Moon JY, Tanimoto M, Gohda T et al. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. Am J Physiol Renal Physiol 2011; 300: F1271-F1282.
36. Takemoto M, Asker N, Gerhardt H et al. A new method for large scale isolation of kidney glomeruli from mice. Am J Pathol 2002; 161: 799-805. (Pubitemid 34988366)
37. Dilauro M, Zimpelmann J, Robertson SJ et al. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease. Am J Physiol Renal Physiol 2010; 298: F1523-F1532.
38. Yu D, Petermann A, Kunter U et al. Urinary podocyte loss is a more specific marker of ongoing glomerular damage than proteinuria. J Am Soc Nephrol 2005; 16: 1733-1741. (Pubitemid 41716479)
39. Joyner J, Neves LAA, Granger JP et al. Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats. Am J Physiol Regul Integr Comp Physiol 2007; 293: 169-177.